Aflac Incorporated (NYSE:AFL) Receives $97.93 Consensus Price Target from Analysts

Aflac Incorporated (NYSE:AFL) has been assigned an average rating of “Hold” from the fifteen research firms that are currently covering the stock, Marketbeat Ratings reports. Three equities research analysts have rated the stock with a sell rating, nine have issued a hold rating and three have issued a buy rating on the company. The average twelve-month price target among brokerages that have issued ratings on the stock in the last year is $97.93.

AFL has been the topic of several recent research reports. JPMorgan Chase & Co. upped their price target on shares of Aflac from $85.00 to $90.00 and gave the company a “neutral” rating in a report on Thursday, October 3rd. UBS Group upped their target price on Aflac from $84.00 to $109.00 and gave the stock a “neutral” rating in a research note on Wednesday, August 14th. Bank of America lifted their price target on Aflac from $115.00 to $124.00 and gave the company a “buy” rating in a research report on Thursday, October 10th. TD Cowen assumed coverage on Aflac in a research report on Wednesday, October 9th. They issued a “hold” rating and a $102.00 price objective on the stock. Finally, Piper Sandler raised their price objective on shares of Aflac from $114.00 to $122.00 and gave the stock an “overweight” rating in a research note on Wednesday, October 2nd.

Aflac Price Performance

Shares of NYSE AFL opened at $109.69 on Tuesday. Aflac has a 52 week low of $75.07 and a 52 week high of $115.50. The business’s 50 day moving average price is $110.36 and its 200 day moving average price is $99.22. The company has a quick ratio of 0.08, a current ratio of 0.08 and a debt-to-equity ratio of 0.32. The firm has a market cap of $60.94 billion, a P/E ratio of 16.59, a P/E/G ratio of 2.13 and a beta of 0.96.

Aflac (NYSE:AFL) last announced its quarterly earnings data on Wednesday, October 30th. The financial services provider reported $2.16 EPS for the quarter, beating the consensus estimate of $1.69 by $0.47. The business had revenue of $2.95 billion during the quarter, compared to analysts’ expectations of $4.30 billion. Aflac had a net margin of 22.02% and a return on equity of 16.34%. The business’s quarterly revenue was down 40.4% compared to the same quarter last year. During the same period in the previous year, the business posted $1.84 EPS. On average, sell-side analysts expect that Aflac will post 7.22 earnings per share for the current year.

Aflac Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Monday, December 2nd. Investors of record on Wednesday, November 20th will be paid a $0.50 dividend. This represents a $2.00 dividend on an annualized basis and a yield of 1.82%. The ex-dividend date of this dividend is Wednesday, November 20th. Aflac’s dividend payout ratio is presently 30.12%.

Hedge Funds Weigh In On Aflac

Hedge funds have recently made changes to their positions in the company. Y.D. More Investments Ltd purchased a new stake in shares of Aflac during the second quarter worth approximately $25,000. Darwin Wealth Management LLC purchased a new stake in shares of Aflac during the third quarter worth $34,000. Covestor Ltd grew its holdings in shares of Aflac by 41.8% during the third quarter. Covestor Ltd now owns 363 shares of the financial services provider’s stock worth $41,000 after buying an additional 107 shares in the last quarter. Kennebec Savings Bank acquired a new stake in shares of Aflac in the third quarter valued at about $45,000. Finally, Cedar Wealth Management LLC purchased a new position in shares of Aflac in the first quarter worth about $50,000. Institutional investors and hedge funds own 67.44% of the company’s stock.

Aflac Company Profile

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.